The Sotyktu Adherence Program delivers support through Quality Use of Medicine education to patients who are signed-up to MedAdvisor App/SMS and prescribed Sotyktu for the treatment of mild to severe plaque psoriasis.
A review published in the Journal of Clinical Medicine (2022) found that only 61% of psoriatic patients are adherent to therapy and only 63% are persistent.1
The Sotyktu Adherence Program consists of 12 messages sent over approximately 9 months and is designed to encourage medication adherence and persistence to help patients achieve better health outcomes.
The program currently demonstrates a 16% increase in scripts filled for Sotyktu among patients receiving the program compared to patients not receiving the program.
For more information about the Sotyktu Adherence Program and to see which of your patients are eligible, visit the Digital Adherence Programs tile within the Health Services Hub in MedAdvisor for Pharmacy and search for Sotyktu.
Ensure your Sotyktu patients are signed-up to the MedAdvisor App to automatically start receiving the program.
Reference: 1. Piragine E, et al. J Clin Med 2022; 11(6): 1506. DOI: 10.3390/jcm11061506